首页> 中文期刊> 《中国医药科学》 >限制性补液治疗急性创伤性休克患者的临床意义

限制性补液治疗急性创伤性休克患者的临床意义

         

摘要

Objective To explore the effect of limited fluid replacement therapy in patients with acute traumatic shock. Methods 56 cases of acute traumatic shock patients curd in our hospital from January 2014 to April 2015were selected as the object, according to the different rehydration therapy, they were divided into control group and study group. Patients in control group were treated with rapid replenishment of sufficient fluids, and patients in study group were treated with limited fluid resuscitation therapy. After the end of treatment, the therapeutic effect of patients was courted, and different therapy complications and mortality etc. situation of the two groups were compared. Results There were statistical differences on prothrombin time (PT), part of the prothrombin time (PT), hemoglobin and platelet count index between study group and control group (P < 0.05). There were 3 cases found complications in study group, accounted for 10.7%, 2 cases died, accounted for 7.1%. There were 11 cases found complications in control group, accounted for 39.3%, 8 cases died, accounted for 28.6%. There were statistical differences between the two groups (P < 0.05). Conclusion The clinical effect of limited fluid replacement therapy in patients with acute traumatic shock is significant. It can improve the coagulation function, prevent complications, and reduce the mortality rate. It is worth learning from.%目的:分析急性创伤性休克患者实施限制性补液疗法的效果。方法于2014年1月~2015年4月我院收治急性创伤性休克患者中挑选56例作为对象,按照不同补液治疗方案将其分成两组:对照组实施足量液体的快速补充,研究组则实施限制性补液处理,治疗结束后统计患者的治疗效果,并比对不同疗法组并发症、病死等情况。结果研究组患者的凝血酶原时间、部分凝血酶原时间、血红蛋白和血小板计数等指标和对照组统计有区别(P <0.05);研究组患者预后并发症3例,占比10.7%;病死2例,占比7.1%;对照组患者预后并发症11例,占比39.3%;病死8例,占比28.6%,两组统计有区别(P <0.05)。结论临床针对急性创伤性休克患者实施限制性补液疗法作用显著,可改善凝血功能,预防并发症,降低病死率,值得借鉴。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号